Effects of rTMS on Hippocampal Endocannabinoids and Depressive-like Behaviors in Adolescent Rats
- 125 Downloads
Depression is a common mental disorder in adolescents, with a prevalence rate of 5.6%. Current anti-depressive options for adolescents are limited: psychological intervention and conventional antidepressants have low efficacy, a delayed onset of action and increased possibility of suicidal risk. Repetitive transcranial magnetic stimulation (rTMS) as an effective and noninvasive physical therapy for adult depression has been investigated in recent years. However, whether it also produces similar effects on juvenile depression and the underlying mechanism are not clearly understood. In this study, chronic unpredictable mild stress (CMS) was applied to 3-week-old male Sprague Dawley rats for 21 days. Then rTMS was performed for seven consecutive days, and the anti-depressive effects were evaluated by behavioral tests including the sucrose preference test (SPT), the forced swimming test (FST), and the novelty suppressed feeding test (NSF). Expression of hippocampal cannabinoid type I receptor (CB1R), 2-arachidonoylglycerol (2-AG) and relative synthetase and degradative enzymes-diacylglycerol lipase (DAGL) and monoacylglycerol lipase (MAGL) were also investigated. The behavioral parameters were also observed after the administration of the selective CB1 receptor antagonist AM251. The results showed that CMS induced a significant decrease in sucrose preference, a significant increase of immobility time in the FST, and an increased latency to feed in the NSF. In addition, reduced hippocampal CB1 receptor, 2-AG level and increased MAGL protein expression level were also observed in CMS rats. Meanwhile, rTMS treatment upregulated 2-AG level in the hippocampus and ameliorated depressive-like behaviors. The anti-depressive effect of rTMS was attenuated by AM251, a specific CB1R antagonist that was administered 30 min before the onset of rTMS by either intraperitoneal administration or hippocampal microinjection. These results indicate that rTMS can be used as an antidepressive therapy for juvenile depression at least partly mediated by increasing hippocampal 2-AG and CB1 receptor expression levels.
KeywordsRepetitive transcranial magnetic stimulation (rTMS) Juvenile depression Endocannabinoid Hippocampus
Repetitive transcranial magnetic stimulation
Chronic unpredictable mild stress
Sucrose preference test
Forced swimming test
Novelty suppressed feeding test
Cannabinoid type I receptor
We thank Dr. Sun XL for language assistance. This project was supported by grant from the National Natural Science Foundation of China (NSFC) to Y. Wang (Grant No. 81671343).
NSFC had no role in the design and conduct of the study; in the collection, management, analysis, and interpretation of the data; or in the preparation, review, or approval of the manuscript.
Compliance with Ethical Standards
Conflict of interest
There are no conflicts of interest relevant to this study.
- 5.Hazell P (2002) Depression in children and adolescents. Clin Evid 7:307–313Google Scholar
- 6.Malhi GS, Bassett D, Boyce P, Bryant R, Fitzgerald PB, Fritz K, Hopwood M, Lyndon B, Mulder R, Murray G, Porter R, Singh AB (2015) Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders. Aust N Z J Psychiatry 49(12):1087–1206. https://doi.org/10.1177/0004867415617657 CrossRefPubMedGoogle Scholar
- 9.Bachmann CJ, Aagaard L, Burcu M, Glaeske G, Kalverdijk LJ, Petersen I, Schuiling-Veninga CC, Wijlaars L, Zito JM, Hoffmann F (2016) Trends and patterns of antidepressant use in children and adolescents from five western countries, 2005–2012. Eur Neuropsychopharmacol 26(3):411–419. https://doi.org/10.1016/j.euroneuro.2016.02.001 CrossRefPubMedGoogle Scholar
- 10.Cipriani A, Zhou X, Del Giovane C, Hetrick SE, Qin B, Whittington C, Coghill D, Zhang Y, Hazell P, Leucht S, Cuijpers P, Pu J, Cohen D, Ravindran AV, Liu Y, Michael KD, Yang L, Liu L, Xie P (2016) Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis. Lancet 388(10047):881–890. https://doi.org/10.1016/S0140-6736(16)30385-3 CrossRefPubMedGoogle Scholar
- 16.Lee TT, Gorzalka BB (2012) Timing is everything: evidence for a role of corticolimbic endocannabinoids in modulating hypothalamic-pituitary-adrenal axis activity across developmental periods. Neuroscience 204:17–30. https://doi.org/10.1016/j.neuroscience.2011.10.006 CrossRefPubMedGoogle Scholar
- 18.Reich CG, Mihalik GR, Iskander AN, Seckler JC, Weiss MS (2013) Adolescent chronic mild stress alters hippocampal CB1 receptor-mediated excitatory neurotransmission and plasticity. Neuroscience 253:444–454. https://doi.org/10.1016/j.neuroscience.2013.08.066 CrossRefPubMedGoogle Scholar
- 21.Wang H, Xue Y, Chen Y, Zhang R, Wang H, Zhang Y, Gan J, Zhang L, Tan Q (2013) Efficacy of repetitive transcranial magnetic stimulation in the prevention of relapse of depression: study protocol for a randomized controlled trial. Trials 14:338. https://doi.org/10.1186/1745-6215-14-338 CrossRefPubMedPubMedCentralGoogle Scholar
- 22.Wang HN, Wang L, Zhang RG, Chen YC, Liu L, Gao F, Nie H, Hou WG, Peng ZW, Tan Q (2014) Anti-depressive mechanism of repetitive transcranial magnetic stimulation in rat: the role of the endocannabinoid system. J Psychiatr Res 51:79–87. https://doi.org/10.1016/j.jpsychires.2014.01.004 CrossRefPubMedGoogle Scholar
- 23.Wang Y, Gu N, Duan T, Kesner P, Blaskovits F, Liu J, Lu Y, Tong L, Gao F, Harris C, Mackie K, Li J, Tan Q, Hill MN, Yuan Z, Zhang X (2017) Monoacylglycerol lipase inhibitors produce pro- or antidepressant responses via hippocampal CA1 GABAergic synapses. Mol Psychiatry 22(2):215–226. https://doi.org/10.1038/mp.2016.22 CrossRefPubMedGoogle Scholar
- 27.Esser SK, Huber R, Massimini M, Peterson MJ, Ferrarelli F, Tononi G (2006) A direct demonstration of cortical LTP in humans: a combined TMS/EEG study. Brain Res Bull 69(1):86–94. https://doi.org/10.1016/j.brainresbull.2005.11.003 CrossRefPubMedGoogle Scholar
- 29.Atsak P, Hauer D, Campolongo P, Schelling G, McGaugh JL, Roozendaal B (2012) Glucocorticoids interact with the hippocampal endocannabinoid system in impairing retrieval of contextual fear memory. Proc Natl Acad Sci USA 109(9):3504–3509. https://doi.org/10.1073/pnas.1200742109 CrossRefPubMedGoogle Scholar
- 30.Wang Y, Cui XL, Liu YF, Gao F, Wei D, Li XW, Wang HN, Tan QR, Jiang W (2011) LPS inhibits the effects of fluoxetine on depression-like behavior and hippocampal neurogenesis in rats. Prog Neuro-Psychopharmacol Biol Psychiatry 35(8):1831–1835. https://doi.org/10.1016/j.pnpbp.2011.07.004 CrossRefGoogle Scholar
- 37.Gaynes BN, Lloyd SW, Lux L, Gartlehner G, Hansen RA, Brode S, Jonas DE, Swinson Evans T, Viswanathan M, Lohr KN (2014) Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and meta-analysis. J Clin Psychiatry 75(5):477–489. https://doi.org/10.4088/JCP.13r08815 quiz 489.CrossRefPubMedGoogle Scholar
- 40.Zhong P, Wang W, Pan B, Liu X, Zhang Z, Long JZ, Zhang HT, Cravatt BF, Liu QS (2014) Monoacylglycerol lipase inhibition blocks chronic stress-induced depressive-like behaviors via activation of mTOR signaling. Neuropsychopharmacology 39(7):1763–1776. https://doi.org/10.1038/npp.2014.24 CrossRefPubMedPubMedCentralGoogle Scholar
- 41.Shearman LP, Rosko KM, Fleischer R, Wang J, Xu S, Tong XS, Rocha BA (2003) Antidepressant-like and anorectic effects of the cannabinoid CB1 receptor inverse agonist AM251 in mice. Behav Pharmacol 14(8):573–582. https://doi.org/10.1097/01.fbp.0000104880.69384.38 CrossRefPubMedGoogle Scholar